Stool test may spot hidden bleeding in heart patients on blood thinners
NCT ID NCT07327853
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test 200 adults who are about to start blood thinners for heart conditions. Each person will provide a stool sample before starting the medication and again three months later. The goal is to see if the fecal immunochemical test (FIT) can detect hidden gastrointestinal bleeding early, which could help doctors take action sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fecal Immunochemical Test (FIT)
What this could lead to
If successful, this could show that FIT is a useful tool for early detection of gastrointestinal bleeding in patients on blood thinners.
What could go wrong
This is an early observational study with only 200 participants, so results may not apply to everyone. The test may not catch all bleeding cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istishari hospital
Amman, 11184, Jordan
Contact Phone: •••-•••-•••• Email: •••••@•••••